$0.92+4.3%Nov 11 close
Reported results on November 13, 2026; they are not in these figures yet.
Figures through June 30, 2026, from the 10-Q filed August 14, 2026
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $76.2K | $2.3M | -96.63% |
| Profit | -$286.5K | -$616.2K | +53.51% |
| Profit per share | -$0.12 | -$0.35 | +65.99% |
| Free Cash Flow | -$422.7K | -$759.4K | +44.33% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
BioNexus Gene Lab Corp reported on November 13, 2026. We are fetching the call transcript; its summary follows once the transcript is in.